Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease

被引:51
作者
Courty, E
Durif, F
Zenut, M
Courty, P
Lavarenne, J
机构
[1] DEPT PSYCHIAT, CLERMONT FERRAND, FRANCE
[2] REG PHARMACOVIGILANCE CTR, CLERMONT FERRAND, FRANCE
关键词
apomorphine; psychosexual disorders; drug dependence;
D O I
10.1097/00002826-199704000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A similar pattern of psychosexual disorders has been observed after longterm treatment with levodopa therapy in four male parkinsonian patients treated with apomorphine for severe on-off motor fluctuations. An acute episode in each case had led them to the hospital in the context of a psychiatric emergency (after punishable sexual acts in two cases). In each case, this episode had been preceded by an increase of self-administered apomorphine, whereas other antiparkinsonian drugs remained unchanged. Questioning had revealed psychosexual disturbances as early as the onset of apomorphine treatment, which tended to progressively worsen with the number of apomorphine daily doses. A decrease in the dosage of apomorphine had been followed by the improvement of the psychiatric condition without worsening of the motor status. Recurrence of psychiatric disorders with similar features had been observed when two patients again increased the number of apomorphine daily injections. The absence of somatic manifestations when apomorphine treatment was withdrawn or reduced, with persistence of psychosexual disturbances, could suggest a psychological dependence from the drug.
引用
收藏
页码:140 / 147
页数:8
相关论文
共 25 条
[1]   BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING-AGENT IN TREATMENT OF PARKINSONS-DISEASE [J].
AGID, Y ;
BONNET, AM ;
POLLAK, P ;
SIGNORET, JL ;
LHERMITTE, F .
LANCET, 1979, 1 (8116) :570-572
[2]   PAINFUL CLITORAL TUMESCENCE DURING BROMOCRIPTINE THERAPY [J].
BLIN, O ;
SCHWERTSCHLAG, US ;
SERRATRICE, G .
LANCET, 1991, 337 (8751) :1231-1232
[3]   NALOXONE PARTLY COUNTERACTS APOMORPHINE SIDE-EFFECTS [J].
BONUCCELLI, U ;
PICCINI, P ;
DELDOTTO, P ;
ROSSI, G ;
CORSINI, GU ;
MURATORIO, A .
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (05) :442-449
[4]   SEXUAL BEHAVIOR DURING L-DOPA TREATMENT FOR PARKINSONISM [J].
BOWERS, MB ;
VANWOERT, M ;
DAVIS, L .
AMERICAN JOURNAL OF PSYCHIATRY, 1971, 127 (12) :1691-&
[5]  
COURTY E, 1993, PSYCHOL MED, V25, P667
[6]   ASSESSMENT OF ERECTOGENIC PROPERTIES OF APOMORPHINE AND YOHIMBINE IN MAN [J].
DANJOU, P ;
ALEXANDRE, L ;
WAROT, D ;
LACOMBLEZ, L ;
PUECH, AJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (06) :733-739
[7]   APOMORPHINE IN TREATMENT OF PARKINSONS-DISEASE - COMPARISON BETWEEN SUBCUTANEOUS AND SUBLINGUAL ROUTES [J].
DEFFOND, D ;
DURIF, F ;
TOURNILHAC, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (01) :101-103
[8]  
DUVOISIN RC, 1972, L DOPA BEHAVIOUR, P57
[9]   L-DOPA AND PATIENT WITH PARKINSONS DISEASE [J].
FANGMAN, A ;
OMALLEY, WE .
AMERICAN JOURNAL OF NURSING, 1969, 69 (07) :1455-1457
[10]   PSYCHOTIC COMPLICATIONS OF LONG-TERM LEVODOPA TREATMENT OF PARKINSONS-DISEASE [J].
FRIEDMAN, A ;
SIENKIEWICZ, J .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (02) :111-113